• Rapid, homogeneous release at a defined pH from 3.0 to 5.5
  • 90% of dose released within 30 minutes for effective targeting
  • Extends Evonik's leadership for oral drug delivery solutions

Attachments

  • Original document
  • Permalink

Disclaimer

Evonik Industries AG published this content on 06 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 October 2020 13:04:03 UTC